medigraphic.com
ISSN 1870-199X (Print)
Órgano oficial de la Facultad de Odontología, UNAM

2014, Number 3

<< Back Next >>

Rev Odont Mex 2014; 18 (3)

Warthin’s tumor: An experience of the General Hospital «Calixto García». Havana, Cuba

Donohue CA, Mori EAD, Sánchez AG, Guzmán GDA, Sánchez RCRA, Constandse CDA, Gaitán CLA

Language: Spanish
References: 43
Page: 164-169
PDF size: 232.01 Kb.


ABSTRACT

Background: Warthin’s tumor, a benign tumor of the salivary glands, was first described by Dr. Hildrebrand in 1896. It was later extensively described by Dr. Warthin in 1929. It represents the second most frequent neoplasia found in the salivary glands. It constitutes 10% of all salivary glands tumors. Methods: A salivary gland retrospective study was conducted at the Pathological Anatomy Department of the «Calixto García» Hospital in Havana, Cuba. The study was conducted in the period comprised between January 2001 and December 2008. Two oral pathology experts re-diagnosed the cases following diagnostic criteria proposed in 2005 by the World Health Organization (WHO). Results: Out of 159 studied cases, 113 (71.1%) were benign tumors (48 male patients, 65 female, average age 50.8 [± 15], age range 20-80 years). Most frequently found tumor was pleomorphic adenoma, which counted 77 cases (68.1%) followed by Warthin’s tumor with 33 cases (20.7%) of all included salivary glands tumors and 29.2% of benign tumors. Conclusions: The present study revealed the fact that Warthin’s tumor proportion is among the highest reported in recent years in scientific literature.


REFERENCES

  1. Yoshimura Y, Gabka J. Clinical evaluation of Warthin’s tumor. An analysis of 43 cases. Int J Oral Surg. 1979; 8: 8-17.

  2. Ethunandan M, Pratt CA, Higgins B, Morrison A, Umar T, Macpherson DW et al. Factors influencing the occurrence of multicentric and ‘recurrent’ Warthin’s tumor: a cross sectional study. Int J Oral Maxillofac Surg. 2008; 37: 831-834.

  3. Sánchez E, Meléndez B, Revelles H, Védia J, Murga C. Tumor de Warthin bilateral. ORL-Dips. 2005; 32: 47-50.

  4. Aguirre JM, Echebarría MA, Martínez-Conde R, Rodríguez C, Burgos JJ, Rivera JM. Warthin tumor. A new hypothesis concerning its development. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85: 60-63.

  5. Yerli H, Avci S, Aydin E, Arikan U. The metaplastic variant of Warthin tumor of the parotid gland: dynamic multislice computerized tomography and magnetic resonance imaging findings with histopathologic correlation in a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109: e95-e98.

  6. Teymoortash A, Krasnewicz A, Werner JA. Clinical features of cystadenolymphoma (Warthin’s tumor) of the parotid gland: a retrospective comparative study of 96 cases. Oral Oncol. 2006; 42: 569-573.

  7. Mejía-Velázquez CP, Durán-Padilla MA, Gómez-Apo E, Quezada-Rivera D, Gaitán-Cepeda LA. Tumors of the salivary gland in Mexicans. A retrospective study of 360 cases. Med Oral Patol Oral Cir Bucal. 2012; 17: e183-e189.

  8. Faur A, Lazăr E, Cornianu M, Dema A, Vidita CG, Găluşcan A. Warthin tumor: a curious entity case reports and review of literature. Rom J Morphol Embryol. 2009; 50: 269-273.

  9. Ellis GL. Lymphoid lesions of salivary glands: malignant and benign. Med Oral Patol Oral Cir Bucal. 2007; 12: e479-e485.

  10. Gaitán-Cepeda LA, Peniche-Becerra AG, Quezada-Rivera D. Trends in frequency and prevalence of oral cancer and oral squamous cell carcinoma in Mexicans. A 20 years retrospective study. Med Oral Patol Oral Cir Bucal. 2011; 16: e1-e5.

  11. Cardoso SV, do Nascimento-Souza KC, de Faria PR, Lima RA, Nascimento MF, Eisenberg AL et al. Warthin’s tumor at the Brazilian National Cancer Institute: additional evidence of homogeneous sex prevalence and association with other neoplasms. ORL J Otorhinolaryngol Relat Spec. 2008; 70: 339-343.

  12. Barnes L. Pathology and genetics of head and neck tumors. Lyon, France: World Health Organization, International Agency for Research on Cancer; 2005.

  13. Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6,982 cases in an eastern Chinese population. Int J Oral Maxillofac Surg. 2010; 39: 235-242.

  14. Chidzonga MM, López-Pérez VM, Portilla-Álvarez AL. Salivary gland tumours in Zimbabwe: report of 282 cases. Int J Oral Maxillofac Surg. 1995; 24: 293-297.

  15. Li LJ, Li Y, Wen YM, Liu H, Zhao HW. Clinical analysis of salivary gland tumor cases in west China in past 50 years. Oral Oncol. 2008; 44: 187-192.

  16. Patil K, Mahima VG, Kalia S. Papillary cystadenomalymphomatosum: case report and review of literature. Indian J Dent Res. 2005; 16: 153-158.

  17. de Oliveria FA, Barroso-Duarte EC, Texeira-Taveira C, Abreu-Máximo A, Carvalho de Aquino E, de Cássia-Alencar R et al. Salivary gland tumor: a review of 599 cases in a Brazilian population. Head Neck Pathol. 2009; 3: 271-275.

  18. Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol. 2008; 44: 407-417.

  19. Tilakaratne WM, Jayasooriya PR, Tennakoon TMPB, Saku T. Epithelial salivary tumors in Sri Lanka: a retrospective study of 713 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108: 90-98.

  20. Poulsen P, Jørgensen K, Grøntved A. Benign and malignant neoplasms of the parotid gland: incidence and histology in the Danish County of Funen. Laryngoscope. 1987; 97: 102-104.

  21. Chávez-Martínez FJ, Romero-Pérez T, González-Marinello S, Lence-Anta JJ, Santos-Martínez T. Riesgos de morir por cáncer en Cuba. Rev Cubana Oncol. 1997; 13: 5-11.

  22. Chedid HM, Rapoport A, Aikawa KF, Menezes-Ados S, Curioni OA. Warthin’s tumor of the parotid gland: study of 70 cases. Rev Col Bras Cir. 2011; 38: 90-94.

  23. Sadetzki S, Oberman B, Mandelzweig L, Chetrit A, Ben-Tal T, Jarus-Hakak A et al. Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer. 2008; 112: 1974-1982.

  24. Peter-Klussmann J, Wittekindt C, Florian-Preuss S, Al Attab A, Schroeder U, Guntinas-Lichius O. High risk for bilateral Warthin tumor in heavy smokers review of 185 cases. Acta Otolaryngol. 2006; 126: 1213-1217.

  25. [acceso 14 de marzo de 2013]. Disponible en: www.ecured.cu/index.php/Tabaquismo_en_Cuba.

  26. Graham H. Smoking prevalence among women in the European community 1950-1990. Soc Sci Med. 1996; 43: 243-254.

  27. Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM et al. Smoking in China: findings of the 1996 National Prevalence Survey. JAMA. 1999; 282: 1247-1253.

  28. Teymoortash A, Lippert BM, Werner JA. Steroid hormone receptors in parotid gland cystadenolymphoma (Warthin’s tumour). Clin Otolaryngol Allied SCI. 2001; 26: 441-446.

  29. Colella G, Biondi P, Itro A, Compilato D, Campisi G. Warthin’s tumor distribution within the parotid gland. A feasible etiologic source from lymph nodal tissue. Minerva Stomatol. 2010; 59: 245-249.

  30. Dalpa E, Gourvas V, Baritaki S, Miyakis S, Samaras V, Barbatis C et al. High prevalence of human herpes virus 8 (HHV-8) in patients with Warthin’s tumors of the salivary gland. J ClinVirol. 2008; 42: 182-185.

  31. O’Neill ID. New insights into the nature of Warthin’s tumour. J Oral Pathol Med. 2009; 38: 145-149.

  32. Teymoortash A, Werner JA, Moll R. Is Warthin’s tumour of the parotid gland a lymph node disease? Histopathology. 2011; 59: 143-145.

  33. Foote FW, Frazell EL. Tumors of the major salivary glands. Cancer.1953; 6: 1065-1133.

  34. Eveson JW, Cawson RA. Warthin’s tumor (cystadenolymphoma) of salivary glands. A clinicopathologic investigation of 278 cases. Oral Surg Oral Med Oral Pathol. 1986; 61: 256-262.

  35. Kennedy TL. Warthin’s tumor: a review indicating no male predominance. Laryngoscope. 1983; 93: 889-891.

  36. Sato T, Morita Y, Hamamoto S, Noikura T, Kawashima K, Matsune S et al. Interpretation of scintigraphy of papillary cystadenoma lymphomatosum (Warthin’s tumor) on the basis of histopathologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996; 82: 101-107.

  37. Monk JS Jr, Church JS. Warthin’s tumor. A high incidence and no sex predominance in central Pennsylvania. Arch Otolaryngol Head Neck Surg. 1992; 118: 477-478.

  38. García OR. Tumores de glándulas salivales. Su comportamiento en 10 años de trabajo (1993-2002). Rev Cubana Estomatol. 2003; 40 (3).

  39. Larraín DC, Madrid A, Capdeville F, Ferrada C. Tumores de glándulas salivales: hallazgos histopatológicos en 168 pacientes. Salivary gland tumors. Histopathological findings in 168 patients. Rev Chilena de Cirugía. 2005; 57 (5): 373-378.

  40. Ito FA, Ito K, Vargas PA, Almeida OP, Lopes MA. Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg. 2005; 34: 533-536.

  41. Ochicha O, Malami S, Mohammed A, Atanda A. A histopathologic study of salivary gland tumors in Kano, northern Nigeria. Indian Journal of Pathology and Microbiology. 2009; 52 (4): 473-476.

  42. Luksic I, Virag M, Manojlovic S, Macan D. Salivary gland tumors: 25 years of experience from a single institution in Croatia. Journal of Cranio-Maxillo-Facial Surgery. 2012; 40: 75-81.

  43. Monk JS Jr, Church JS. Warthin’s tumor. A high incidence and no sex predominance in central Pennsylvania. Arch Otolaryngol Head Neck Surg. 118: 477-478.




2020     |     www.medigraphic.com